We report a case of progressive multifocal leukoencephalopathy after treatment with nivolumab, a PD-1 blocker that is used to restore impaired T-cell responses in patients with cancer and infections. This evidence concerns the gene PDCD1 and progressive multifocal leukoencephalopathy.